Results 61 to 70 of about 1,484 (137)

Research progress and future perspectives in proteolysis-targeting chimeras. [PDF]

Front Pharmacol
Wu N, Xu Z, Dai S, Wang Q.
europepmc   +1 more source

Lysosome-centered nanomedicine for cancer therapy: mechanisms, materials, and modalities. [PDF]

J Nanobiotechnology
Xu R, Li N, Chen X, Zou M, Feng W, Zhou Z, Guo Z, Zhao X, Liu S, Cui L.   +9 more
europepmc   +1 more source

HNRNPU and architectural lncRNAs as nuclear tethers of epithelial state stability. [PDF]

EMBO Mol Med
Luo L, Sen GL.
europepmc   +1 more source

Unlocking the "undruggable": current landscape and emerging frontiers in lysosomal receptor-mediated protein degradation. [PDF]

Drug Deliv
Ma YM, Xia HF, Xiao YL, Yu ZL.
europepmc   +1 more source

From Lock-and-Key to Velcro: Glycan-Dependent T Cell Recruiter Redefines Cancer Cell Targeting With Density-Dependent Recognition. [PDF]

MedComm (2020)
Wei P, Tong A, Zhao L.
europepmc   +1 more source

Multiaxial Biophysical Control of Oncogenic Phase Separation by Indoleamines: A Proof-of-Concept Synthesis of Landscape-Level Regulation. [PDF]

J Pineal Res
Loh D, Chuffa LGA, Seiva FRF, Reiter RJ.
europepmc   +1 more source

Phase separation as an emerging regulatory framework in antibody class switching and genome stability. [PDF]

Front Immunol
Refaat AM, Shimizu H, Yasuhara T.
europepmc   +1 more source

Enhancing small-molecule-mediated translational control through multivalent RNA aptamers. [PDF]

Nucleic Acids Res
Feng HY, Wu XJ, Li XH, Liu Y, Xu L, Xing X.   +5 more
europepmc   +1 more source

Liquid-liquid phase separation of peptides: a molecular foundation for next-generation biomaterials. [PDF]

Chem Sci
Lu L, Wang H.
europepmc   +1 more source

Engineering spherical nucleic acids for precision cancer therapy: design strategies and medical applications. [PDF]

Theranostics
Wang Y, Wu W, Yao F.
europepmc   +1 more source